What is the Fagerström Test for Nicotine Dependence?

The Fagerström Test for Nicotine Dependence (FTND) is a validated 6-item questionnaire developed by Heatherton et al. (1991) to measure physical nicotine dependence in cigarette smokers. It quantifies dependence severity to guide smoking cessation pharmacotherapy selection.

How is the Fagerström test scored?

FTND total ranges 0-10 across 6 items. Score interpretation: 0-2 = very low dependence; 3-4 = low; 5 = moderate; 6-7 = high; 8-10 = very high dependence. Higher scores indicate greater physiological nicotine dependence and need for more intensive cessation support.

What does the Fagerström score mean for treatment?

FTND score guides pharmacotherapy intensity: 0-4 (low) = single NRT may suffice; 5 (moderate) = standard pharmacotherapy (patch, gum, or prescription); 6-10 (high-very high) = combination NRT (patch + short-acting) or prescription therapy (varenicline or bupropion) strongly recommended.

What is the most effective smoking cessation medication?

Varenicline (Chantix/Champix) is the most effective single agent, approximately doubling quit rates vs placebo (NNT ~8). Combination NRT (patch + gum or lozenge) and bupropion are also highly effective. All pharmacotherapies are significantly more effective when combined with behavioral counseling.

What is combination NRT and when should it be used?

Combination NRT uses a nicotine patch for steady background delivery plus a short-acting form (gum, lozenge, nasal spray) for breakthrough cravings. It is more effective than patch alone and is recommended for moderate-to-high FTND scores (≥5) or for patients who have not succeeded with single NRT.

What are nicotine withdrawal symptoms and how long do they last?

Common nicotine withdrawal symptoms include irritability, anxiety, difficulty concentrating, restlessness, increased appetite, and strong cravings. Withdrawal peaks at 24-72 hours after cessation and most physical symptoms resolve within 2-4 weeks, though psychological cravings can persist for months.

How does bupropion help with smoking cessation?

Bupropion (Wellbutrin/Zyban) is an antidepressant that reduces nicotine cravings and withdrawal symptoms through dopaminergic and noradrenergic mechanisms. It is particularly useful for smokers with comorbid depression and approximately doubles quit rates vs placebo. It is contraindicated with seizure disorders.

What is the 5As framework for tobacco cessation?

The 5As framework is a clinical approach for tobacco cessation: Ask (screen all patients for tobacco use), Advise (give clear cessation advice), Assess (evaluate motivation and dependence with FTND), Assist (prescribe pharmacotherapy and counseling), Arrange (follow-up within 1-2 weeks of quit date). USPSTF recommends this structured approach.

Is FTND valid for e-cigarette or vaping users?

No. FTND was developed and validated for cigarette smokers. E-cigarettes deliver nicotine differently, and the behavioral items (morning smoking, forbidden-place refraining) do not map directly to vaping. Modified tools exist but lack equivalent validation evidence.

What is a quit line and how does it help?

Quit lines (1-800-QUIT-NOW in the US, 0800 022 4332 in UK) provide free telephone-based behavioral counseling for smoking cessation. Systematic reviews show telephone counseling increases quit rates by approximately 60% compared to self-help alone. Providing quitline referral alongside FTND-guided pharmacotherapy is a USPSTF Grade A recommendation.

How many quit attempts does it take to stop smoking?

Research suggests smokers make an average of 8-11 quit attempts before achieving sustained abstinence. Each attempt is an opportunity to learn about personal triggers and barriers. Clinicians should maintain a non-judgmental approach and treat relapse as expected rather than failure.

What is the USPSTF recommendation for tobacco cessation?

USPSTF Grade A recommendation (highest level) for tobacco cessation counseling and pharmacotherapy for all adults who smoke. This means clinicians should routinely identify tobacco users, advise cessation, and offer both behavioral counseling and FDA-approved pharmacotherapy to all motivated smokers.

Online Medical Tools — Fagerstrom Test

Printed on 9/3/2026

For informational purposes only. This is not medical advice.

Mental Health

Fagerstrom Test

The Fagerstrom Test for Nicotine Dependence (FTND) is a brief smoking dependence scale used to stratify nicotine dependence severity and support cessation planning.

Formula: FTND total = sum of 6 item scores (range 0-10).

Time to first cigarette after waking

Difficult to refrain in forbidden places

Cigarette most hated to give up

Cigarettes per day

Smoke more during first hours after waking

Smoke even when ill in bed most of day

Save your results with a free account

Keep a history of calculations, favorite tools, and access your dashboard anytime.

Create free account Sign in

How It Works

Answer 6 Questions About Smoking Behavior

The patient answers 6 questions about their current cigarette smoking patterns: time to first cigarette after waking, difficulty refraining in forbidden places, which cigarette they would most hate to give up, cigarettes per day, whether they smoke more in the morning, and whether they smoke even when ill in bed.

Sum Weighted Item Scores (0–10)

Items are scored with different weighting: time to first cigarette (0-3), cigarettes per day (0-3), and other items (0-1 each). Total FTND score ranges from 0 to 10.

Interpret Dependence Level and Guide Cessation Therapy

0-2 = very low dependence; 3-4 = low; 5 = moderate; 6-7 = high; 8-10 = very high. Higher scores indicate greater physiological nicotine dependence and support more intensive pharmacotherapy (combination NRT or prescription medications) plus behavioral counseling.

Who Uses the Fagerstrom Test

Primary Care Smoking Cessation Counseling

Primary Care Physicians

FTND quantifies nicotine dependence severity to guide pharmacotherapy intensity selection during smoking cessation counseling in primary care, where USPSTF recommends tobacco cessation interventions for all tobacco users (Grade A).

Motivational Enhancement for Cessation

Health Coaches & Counselors

Sharing FTND results with patients reinforces that smoking difficulty reflects physiological dependence — not personal weakness — which can normalize the struggle and increase motivation to pursue evidence-based pharmacotherapy.

Pharmacotherapy Intensity Selection

Pharmacists & Prescribers

FTND score directly guides medication selection: low scores (0-4) may respond to single NRT; moderate scores (5) warrant standard pharmacotherapy; high scores (6-10) benefit from combination NRT (patch + short-acting) or prescription therapy (varenicline, bupropion).

Smoking Cessation Program Intake

Cessation Program Coordinators

Tobacco cessation programs use FTND at intake to stratify participants by dependence severity, tailor intervention intensity, and predict which participants need more intensive pharmacological and behavioral support to achieve abstinence.

Research and Clinical Trial Stratification

Clinical Researchers

FTND is widely used in smoking cessation clinical trials as a stratification variable at randomization to ensure balanced dependence severity across treatment arms, and as a predictor of treatment response outcomes.

Pro Tips

Time to First Cigarette Is the Single Most Predictive Item

The time to first cigarette after waking is the most powerful predictor of nicotine dependence severity and cessation difficulty. Smoking within 5 minutes indicates severe physiological dependence. This item alone often guides pharmacotherapy intensity more than the total score.

Varenicline Doubles Quit Rates Vs Placebo

Varenicline (Chantix/Champix) is the most effective single pharmacotherapy for smoking cessation, approximately doubling quit rates compared to placebo (NNT ~8, Cahill et al., Cochrane 2016). It is first-line for patients with FTND ≥5 who are motivated to quit.

Combination NRT Outperforms Patch Alone

Combining a nicotine patch (steady-state delivery) with a short-acting form (gum, lozenge, inhaler) for breakthrough cravings is more effective than patch alone. Combination NRT is recommended for patients with FTND ≥5 who prefer or require non-prescription options.

Bupropion Is Useful for Comorbid Depression

Bupropion (Wellbutrin/Zyban) improves smoking cessation quit rates and is particularly useful for patients with comorbid depression or a history of depression, where antidepressant effects complement cessation support. It is contraindicated with seizure history or eating disorders.

Behavioral Counseling Dramatically Increases Success

All pharmacotherapy is significantly more effective when combined with behavioral counseling. Quitlines (1-800-QUIT-NOW in the US) provide free telephone counseling and have been shown to triple success rates. The 5As framework (Ask, Advise, Assess, Assist, Arrange) structures clinical cessation conversations.

Nicotine Withdrawal Peaks at 24-72 Hours

Nicotine withdrawal is most intense in the first 24-72 hours after cessation and gradually improves over 2-4 weeks. Patients should be warned about withdrawal symptoms (irritability, anxiety, difficulty concentrating, increased appetite, insomnia) to prevent early relapse during the most difficult period.

E-Cigarettes: Controversial but Potentially Useful for Some

E-cigarettes and vaping have controversial evidence for cessation. Some guidelines (NICE, UK) recommend them as harm reduction tools for smokers who have failed NRT and varenicline. US guidelines are more cautious. The evidence base is evolving; FTND-guided discussion can help individualize recommendations.

Most Smokers Need Multiple Quit Attempts

On average, smokers require 8-11 quit attempts before achieving long-term abstinence. Each attempt provides learning about triggers and barriers. Clinicians should maintain a supportive, non-judgmental approach and not interpret relapse as failure but as a normal part of the cessation process.

FTND Was Validated for Cigarettes Not Other Tobacco Products

The FTND was developed and validated specifically for cigarette smokers. It is not directly applicable to cigar, pipe, smokeless tobacco, or e-cigarette users. Modified versions exist for some non-cigarette products, but standardization is limited.

Common Questions About Your Results

Evidence-Based Methodology

Fagerström Test for Nicotine Dependence published by Heatherton et al. (Br J Addict 1991) as a revision of the earlier Fagerström Tolerance Questionnaire (1978). Validated across multiple populations with internal consistency α=0.61. Time-to-first-cigarette as the most predictive item: Baker et al. (Nicotine Tob Res 2007). Varenicline efficacy NNT ~8: Cahill et al. (Cochrane 2016). Combination NRT: Fiore et al. 2008 Clinical Practice Guideline (USDHHS). USPSTF Grade A recommendation for tobacco cessation counseling and pharmacotherapy.

Clinical Content Trust

Last reviewed:: April 21, 2026
Guideline version:: General evidence framework v2026.04
Source set version:: Primary-source set v1

How to Interpret Your Result

Higher FTND scores indicate greater nicotine dependence burden and typically support stronger cessation intervention intensity.

When to Use This Tool

Use during tobacco-use assessment to stratify dependence before counseling and cessation treatment selection.

Limitations

FTND emphasizes cigarette-smoking behavior and may not fully capture dependence in mixed-product users or non-cigarette nicotine delivery patterns.

For related assessments, see Pack-Year Calculator, COPD GOLD and BODE Index.

Disclaimer: This tool is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about your health.

Changelog

April 21, 2026 · trust-baseline
Clinical trust metadata enabled for this tool page with structured review/version fields.

Related Tools

Pulmonology